Also, in mice with pre-existing obesity, short-term pharmacologic antagonism of CCR2 reduces adipose tissue macrophage content and improves in vivo insulin sensitivity [60]. The gene discussed is CCR2; the disease is obesity due to melanocortin 4 receptor deficiency.